Two distinct mechanisms regulate recruitment of murine leukemia virus envelope protein to retroviral assembly sites

Virology

Volumn 405, Issue 2, 2010, Pages 548-555

  Lucas, Tiffany M ^a   Lyddon, Terri D ^a   Grosse, Sarah A ^a   Johnson, Marc C ^a  

^a University of Missouri   (United States)

Author keywords

Assembly; Cytoplasmic domain; Env; HIV 1; MLV; Pseudotype; RD114; Recruitment; Retrovirus

Indexed keywords

VIRUS ENVELOPE PROTEIN;

ARTICLE; CELL LINE; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINE LEUKEMIA VIRUS; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN DOMAIN; SCANNING ELECTRON MICROSCOPY; VIRUS ASSEMBLY; VIRUS MUTANT; VIRUS PARTICLE;

ANIMALS; CELL LINE; CYTOPLASM; GENE EXPRESSION REGULATION, VIRAL; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; LEUKEMIA VIRUS, MURINE; MUTATION; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; VIRAL ENVELOPE PROTEINS; VIRION; VIRUS ASSEMBLY;

HUMAN IMMUNODEFICIENCY VIRUS 1; MURINE LEUKEMIA VIRUS;

EID: 77955659702     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.06.017     Document Type: Article

References (59)

1. Aguilar H.C., Anderson W.F., Cannon P.M. Cytoplasmic tail of Moloney murine leukemia virus envelope protein influences the conformation of the extracellular domain: implications for mechanism of action of the R Peptide. J. Virol. 2003, 77(2):1281-1291.
2. Andersen K.B., Diep H.A., Zedeler A. Murine leukemia virus transmembrane protein R-peptide is found in small virus core-like complexes in cells. J. Gen. Virol. 2006, 87(Pt 6):1583-1588.
3. Benting J., Rietveld A., Ansorge I., Simons K. Acyl and alkyl chain length of GPI-anchors is critical for raft association in vitro. FEBS Lett. 1999, 462(1-2):47-50.
4. Blot V., Lopez-Verges S., Breton M., Pique C., Berlioz-Torrent C., Grange M.P. The conserved dileucine- and tyrosine-based motifs in MLV and MPMV envelope glycoproteins are both important to regulate a common Env intracellular trafficking. Retrovirology 2006, 3:62.
5. Bobkova M., Stitz J., Engelstadter M., Cichutek K., Buchholz C.J. Identification of R-peptides in envelope proteins of C-type retroviruses. J. Gen. Virol. 2002, 83(Pt 9):2241-2246.
6. Bouard D., Sandrin V., Boson B., Negre D., Thomas G., Granier C., Cosset F.L. An acidic cluster of the cytoplasmic tail of the RD114 virus glycoprotein controls assembly of retroviral envelopes. Traffic 2007, 8(7):835-847.
7. Briggs J.A., Wilk T., Fuller S.D. Do lipid rafts mediate virus assembly and pseudotyping?. J. Gen. Virol. 2003, 84(Pt 4):757-768.
8. Chertova E., Chertov O., Coren L.V., Roser J.D., Trubey C.M., Bess J.W., Sowder R.C., Barsov E., Hood B.L., Fisher R.J., Nagashima K., Conrads T.P., Veenstra T.D., Lifson J.D., Ott D.E. Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J. Virol. 2006, 80(18):9039-9052.
9. Christodoulopoulos I., Cannon P.M. Sequences in the cytoplasmic tail of the gibbon ape leukemia virus envelope protein that prevent its incorporation into lentivirus vectors. J. Virol. 2001, 75(9):4129-4138.
10. Dong J., Dubay J.W., Perez L.G., Hunter E. Mutations within the proteolytic cleavage site of the Rous sarcoma virus glycoprotein define a requirement for dibasic residues for intracellular cleavage. J. Virol. 1992, 66:865-874.
11. Dubay J.W., Dubay S.R., Shin H.J., Hunter E. Analysis of the cleavage site of the human immunodeficiency virus type 1 glycoprotein: requirement of precursor cleavage for glycoprotein incorporation. J. Virol. 1995, 69(8):4675-4682.
12. Freed E.O., Martin M.A. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. J. Virol. 1996, 70(1):341-351.
13. Freed E.O., Risser R. The role of envelope glycoprotein processing in murine leukemia virus infection. J. Virol. 1987, 61(9):2852-2856.
14. Goodman L.J., Kain S.R., Firestone G.L. Trafficking of wild-type and an endoproteolytic-site mutant of the mouse mammary tumor virus glycoprotein. J. Biol. Chem. 1993, 268(4):2329-2336.
15. Green N., Shinnick T.M., Witte O., Ponticelli A., Sutcliffe J.G., Lerner R.A. Sequence-specific antibodies show that maturation of Moloney leukemia virus envelope polyprotein involves removal of a COOH-terminal peptide. Proc. Natl. Acad. Sci. U. S. A. 1981, 78(10):6023-6027.
16. Gropp M., Itsykson P., Singer O., Ben-Hur T., Reinhartz E., Galun E., Reubinoff B.E. Stable genetic modification of human embryonic stem cells by lentiviral vectors. Mol. Ther. 2003, 7(2):281-287.
17. Guo H.G., Veronese F.M., Tschachler E., Pal R., Kalyanaraman V.S., Gallo R.C., Reitz M.S. Characterization of an HIV-1 point mutant blocked in envelope glycoprotein cleavage. Virology 1990, 174(1):217-224.
18. Henderson L.E., Sowder R., Copeland T.D., Smythers G., Oroszlan S. Quantitative separation of murine leukemia virus proteins by reversed-phase high-pressure liquid chromatography reveals newly described gag and env cleavage products. J. Virol. 1984, 52(2):492-500.
19. Januszeski M.M., Cannon P.M., Chen D., Rozenberg Y., Anderson W.F. Functional analysis of the cytoplasmic tail of Moloney murine leukemia virus envelope protein. J. Virol. 1997, 71(5):3613-3619.
20. Jiang J., Aiken C. Maturation of the viral core enhances the fusion of HIV-1 particles with primary human T cells and monocyte-derived macrophages. Virology 2006, 346(2):460-468.
21. Jorgenson R.L., Vogt V.M., Johnson M.C. Foreign glycoproteins can be actively recruited to virus assembly sites during pseudotyping. J. Virol. 2009, 83(9):4060-4067.
22. Klasse P.J. Modeling how many envelope glycoprotein trimers per virion participate in human immunodeficiency virus infectivity and its neutralization by antibody. Virology 2007, 369(2):245-262.
23. Kubo Y., Amanuma H. Mutational analysis of the R peptide cleavage site of Moloney murine leukaemia virus envelope protein. J. Gen. Virol. 2003, 84(Pt 8):2253-2257.
24. Kubo Y., Tominaga C., Yoshii H., Kamiyama H., Mitani C., Amanuma H., Yamamoto N. Characterization of R peptide of murine leukemia virus envelope glycoproteins in syncytium formation and entry. Arch. Virol. 2007, 152(12):2169-2182.
25. Leung K., Kim J.O., Ganesh L., Kabat J., Schwartz O., Nabel G.J. HIV-1 assembly: viral glycoproteins segregate quantally to lipid rafts that associate individually with HIV-1 capsids and virions. Cell Host Microbe 2008, 3(5):285-292.
26. Lodge R., Delamarre L., Lalonde J.P., Alvarado J., Sanders D.A., Dokhelar M.C., Cohen E.A., Lemay G. Two distinct oncornaviruses harbor an intracytoplasmic tyrosine-based basolateral targeting signal in their viral envelope glycoprotein. J. zVirol. 1997, 71(7):5696-5702.
27. Lopez-Verges S., Camus G., Blot G., Beauvoir R., Berlioz-Torrent C. Tail-interacting protein TIP47 is a connector between Gag and Env and is required for Env incorporation into HIV-1 virions. Proc. Natl. Acad. Sci. 2006, 103:14947-14952.
28. Loving R., Li K., Wallin M., Sjoberg M., Garoff H. R-Peptide cleavage potentiates fusion-controlling isomerization of the intersubunit disulfide in Moloney murine leukemia virus Env. J. Virol. 2008, 82(5):2594-2597.
29. Lucas T.M., Lyddon T.D., Cannon P.M., Johnson M.C. Pseudotyping incompatibility between HIV-1 and gibbon ape leukemia virus Env is modulated by Vpu. J. Virol. 2010, 84(6):2666-2674.
30. Machida C.A., Kabat D. Role of partial proteolysis in processing murine leukemia virus membrane envelope glycoproteins to the cell surface. A viral mutant with uncleaved glycoprotein. J. Biol. Chem. 1982, 257(23):14018-14022.
31. Magnus C., Rusert P., Bonhoeffer S., Trkola A., Regoes R.R. Estimating the stoichiometry of human immunodeficiency virus entry. J. Virol. 2009, 83(3):1523-1531.
32. Mammano F., Kondo E., Sodroski J., Bukovsky A., Gottlinger H.G. Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains. J. Virol. 1995, 69(6):3824-3830.
33. McCune J.M., Rabin L.B., Feinberg M.B., Lieberman M., Kosek J.C., Reyes G.R., Weissman I.L. Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus. Cell 1988, 53(1):55-67.
34. Moulard M., Hallenberger S., Garten W., Klenk H.D. Processing and routage of HIV glycoproteins by furin to the cell surface. Virus Res. 1999, 60(1):55-65.
35. Murakami T., Freed E.O. Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41 cytoplasmic tail. J. Virol. 2000, 74(8):3548-3554.
36. Pickl W.F., Pimentel-Muinos F.X., Seed B. Lipid rafts and pseudotyping. J. Virol. 2001, 75(15):7175-7183.
37. Ragheb J.A., Anderson W.F. pH-independent murine leukemia virus ecotropic envelope-mediated cell fusion: implications for the role of the R peptide and p12E TM in viral entry. J. Virol. 1994, 68(5):3220-3231.
38. Rein A., Mirro J., Haynes J.G., Ernst S.M., Nagashima K. Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein. J. Virol. 1994, 68(3):1773-1781.
39. Rozenberg-Adler Y., Conner J., Aguilar-Carreno H., Chakraborti S., Dimitrov D.S., Anderson W.F. Membrane-proximal cytoplasmic domain of Moloney murine leukemia virus envelope tail facilitates fusion. Exp. Mol. Pathol. 2008, 84(1):18-30.
40. Sandrin V., Cosset F.L. Intracellular versus cell surface assembly of retroviral pseudotypes is determined by the cellular localization of the viral glycoprotein, its capacity to interact with Gag, and the expression of the Nef protein. J. Biol. Chem. 2006, 281(1):528-542.
41. Sandrin V., Muriaux D., Darlix J.L., Cosset F.L. Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses. J. Virol. 2004, 78(13):7153-7164.
42. Sandrin V., Bouard D., Boson B., Negre D., Thomas G., Granier C., Cosset F.-L. Interaction of a new sorting motif and its cellular effector controls retroviral envelope assembly. Retroviruses abstract book 2006.
43. Saphire A.C., Gallay P.A., Bark S.J. Proteomic analysis of human immunodeficiency virus using liquid chromatography/tandem mass spectrometry effectively distinguishes specific incorporated host proteins. J. Proteome Res. 2006, 5(3):530-538.
44. Scheiffele P., Rietveld A., Wilk T., Simons K. Influenza viruses select ordered lipid domains during budding from the plasma membrane. J. Biol. Chem. 1999, 274(4):2038-2044.
45. Schnierle B.S., Stitz J., Bosch V., Nocken F., Merget-Millitzer H., Engelstadter M., Kurth R., Groner B., Cichutek K. Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells. Proc. Natl. Acad. Sci. U. S. A. 1997, 94(16):8640-8645.
46. Sherer N.M., Lehmann M.J., Jimenez-Soto L.F., Ingmundson A., Horner S.M., Cicchetti G., Allen P.G., Pypaert M., Cunningham J.M., Mothes W. Visualization of retroviral replication in living cells reveals budding into multivesicular bodies. Traffic 2003, 4(11):785-801.
47. Sjoberg M., Wallin M., Lindqvist B., Garoff H. Furin cleavage potentiates the membrane fusion-controlling intersubunit disulfide bond isomerization activity of leukemia virus Env. J. Virol. 2006, 80(11):5540-5551.
48. Stitz J., Buchholz C.J., Engelstadter M., Uckert W., Bloemer U., Schmitt I., Cichutek K. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1. Virology 2000, 273(1):16-20.
49. Taylor G.M., Sanders D.A. Structural criteria for regulation of membrane fusion and virion incorporation by the murine leukemia virus TM cytoplasmic domain. Virology 2003, 312(2):295-305.
50. Thomas A., Gray K.D., Roth M.J. Analysis of mutations within the cytoplasmic domain of the Moloney murine leukemia virus transmembrane protein. Virology 1997, 227(2):305-313.
51. Waheed A.A., Freed E.O. Lipids and membrane microdomains in HIV-1 replication. Virus Res. 2009, 143(2):162-176.
52. Wilk T., Pfeiffer T., Bosch V. Retained in vitro infectivity and cytopathogenicity of HIV-1 despite truncation of the C-terminal tail of the env gene product. Virology 1992, 189(1):167-177.
53. Wyma D.J., Jiang J., Shi J., Zhou J., Lineberger J.E., Miller M.D., Aiken C. Coupling of human immunodeficiency virus type 1 fusion to virion maturation: a novel role of the gp41 cytoplasmic tail. J. Virol. 2004, 78(7):3429-3435.
54. Yang C., Compans R.W. Analysis of the murine leukemia virus R peptide: delineation of the molecular determinants which are important for its fusion inhibition activity. J. Virol. 1997, 71(11):8490-8496.
55. Yang X., Kurteva S., Ren X., Lee S., Sodroski J. Stoichiometry of envelope glycoprotein trimers in the entry of human immunodeficiency virus type 1. J. Virol. 2005, 79(19):12132-12147.
56. Young J.A., Bates P., Willert K., Varmus H.E. Efficient incorporation of human CD4 protein into avian leukosis virus particles. Science 1990, 250(4986):1421-1423.
57. Zavorotinskaya T., Albritton L.M. Failure To cleave murine leukemia virus envelope protein does not preclude its incorporation in virions and productive virus-receptor interaction. J. Virol. 1999, 73(7):5621-5629.
58. Zhao Y., Azam S., Thorpe R. Comparative studies on cellular gene regulation by HIV-1 based vectors: implications for quality control of vector production. Gene Ther. 2005, 12(4):311-319.
59. Zufferey R., Nagy D., Mandel R.J., Naldini L., Trono D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 1997, 15(9):871-875.